79: WNT16B, a new biomarker of senescent cells in vitro and in vivo, is necessary for the p53-dependent activation of p21WAF1 in cellular senescence

Romuald, Binet; Ythier, Damien; Robles, Ana; Collado, Manuel; Larrieu, Delphine; Brambilla, Elisabeth; Brambilla, Christian; Serrano, Manuel; Harris, Curtis; Pedeux, Rémy

doi:10.1016/S0007-4551(15)31172-3

79: WNT16B, a new biomarker of senescent cells in vitro and in vivo, is necessary for the p53-dependent activation of p21WAF1 in cellular senescence

Auteurs : Romuald B¹, Ythier D¹, Robles A¹, Collado M¹, Larrieu D¹, Brambilla E¹, Brambilla C¹, Serrano M¹, Harris C¹, Pedeux R¹

Affiliations : ¹Inserm U917-Mica – Rennes

Date 2010 Mars, Vol 97, Num 1, Supplement, pp S67-S67Revue : Bulletin du cancerDOI : 10.1016/S0007-4551(15)31172-3

Aucun résumé disponible

Source : Elsevier-Masson

Accès à l'article

Accès restreint

Accès à distance aux ressources électroniques :

Exporter

Citer cet article

Romuald B, Ythier D, Robles A, Collado M, Larrieu D, Brambilla E, Brambilla C, Serrano M, Harris C, Pedeux R. 79: WNT16B, a new biomarker of senescent cells in vitro and in vivo, is necessary for the p53-dependent activation of p21WAF1 in cellular senescence. Bull Cancer. 2010 Mar;97(1):S67-S67.

Indicateur SJR (2010) : 0.259